Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
BMJ
.
2020 Mar 26;368:m1256.
doi: 10.1136/bmj.m1256.
Author
Janice Hopkins Tanne
1
Affiliation
1
New York, USA.
PMID:
32217555
DOI:
10.1136/bmj.m1256
No abstract available